Anti-pneumococcal antibody response in normal subjects: A meta-analysis

被引:98
作者
Go, ES [1 ]
Ballas, ZK [1 ]
机构
[1] UNIV IOWA HOSP & CLIN,DEPT INTERNAL MED,IOWA CITY,IA 52242
关键词
immunodeficiency; antibody; pneumococcal vaccine; anti-polysaccharide antibody; Streptococcus pneumoniae; meta-analysis; antibody deficiency;
D O I
10.1016/S0091-6749(96)70244-0
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The diagnosis of anti-polysaccharide antibody deficiency is based on the presence of normal serum immunoglobulin levels and the lack of specific antibody response to polysaccharide antigens, such as the pneumococcal vaccine. However, a normal response to pneumococcal vaccine is not well defined. ''Modified meta-analysis'' was undertaken in an attempt to define the normal antibody response to pneumococcal vaccine. Methods: Studies identified by a MEDLINE search were selected Data of the normal control groups, rather than the patient groups, were collated for analysis. Results: Twenty-three studies fulfilled the selection criteria. Prevaccination antibody titers, postvaccination titers, and post- to prevaccination titer. ratios varied widely. On the basis of weighted mean ratios, serotype 8 appeared to be the most antigenic. It appeared that normal subjects do not mount a response of even a twofold increase in antibody titer to all the serotypes present in the vaccine. Moreover; no minimal absolute antibody level that could be of diagnostic value, either before or after vaccination, was evident. Conclusion: Response to pneumococcal vaccine among normal subjects varies widely. Better designed and prospective studies are needed to define the parameters of a normal antibody response to pneumococcal vaccine so that uniform guidelines of interpretation can be formulated.
引用
收藏
页码:205 / 215
页数:11
相关论文
共 50 条
  • [1] ADDIEGO JE, 1980, LANCET, V2, P450
  • [2] AN IMMUNODEFICIENCY CHARACTERIZED BY IMPAIRED ANTIBODY-RESPONSES TO POLYSACCHARIDES
    AMBROSINO, DM
    SIBER, GR
    CHILMONCZYK, BA
    JERNBERG, JB
    FINBERG, RW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (13) : 790 - 793
  • [3] AMMANN AJ, 1980, P SOC EXP BIOL MED, V164, P312
  • [4] AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447
  • [5] BARRETT DJ, 1981, REV INFECT DIS, V3, pS179
  • [6] BEAM TR, 1980, JAMA-J AM MED ASSOC, V244, P2621
  • [7] BIRGENS HS, 1983, SCAND J HAEMATOL, V30, P324
  • [8] BORGONO JM, 1978, P SOC EXP BIOL MED, V157, P148, DOI 10.3181/00379727-157-40010
  • [9] PNEUMOCOCCAL VACCINE - PAST, PRESENT, AND FUTURE
    BROOME, CV
    BREIMAN, RF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) : 1506 - 1508
  • [10] CONSENSUS ON DIAGNOSIS AND MANAGEMENT OF PRIMARY ANTIBODY DEFICIENCIES
    CHAPEL, HM
    COLE, P
    GABRIEL, C
    MILLA, P
    MORGAN, G
    SCADDING, G
    WINFIELD, D
    BRENNAN, V
    CARNE, S
    EWART, H
    HORN, A
    JARVIS, F
    BROWN, D
    HAENEY, M
    LEVINSKY, R
    THOMPSON, R
    WEBSTER, D
    WALLINGTON, T
    [J]. BRITISH MEDICAL JOURNAL, 1994, 308 (6928) : 581 - 585